...test to detect early-stage cancer and minimal residual disease based on DNA methylation sequencing. Sarepta, Hansa...
...Therapeutics Inc. (NASDAQ:SRPT) has gained an exclusive, global license to develop and promote imlifidase from Hansa...
...from Glenmark Pharmaceuticals Ltd. (NSE:GLENMARK; BSE:532296) to treat mild to moderate COVID-19. BioCentury Staff IdeS, imlifidase Avigan, favipiravir (T-705) Hansa...

...VX-445/VX-661/VX-770) Turalio, pexidartinib (PLX3397) Xiidra, lifitegrast (SAR 1118, SHP606) Zemdri, plazomicin (achn-490) Gilead Sciences Inc. Bristol Myers Squibb Co. Acceleron Pharma Inc. Hansa...

...problems plaguing gene therapy -- immune responses against viral vectors -- by adapting a strategy Hansa...
...published a possible way around the problem. The approach centers on a bacterial enzyme that Hansa...
...idea is to deliver it just before a gene therapy to prevent anti-vector antibody responses. Hansa...

...first CBO. He was VP, business development at the Upjohn unit of Pfizer Inc. (NYSE:PFE). Hansa...
...He was global head of healthcare at Degroof Petercam Investment Bank. Robin Sawka, BioCentury Staff Acadia Pharmaceuticals Inc. Hansa...

...a veteran of Sorin Capital Management, Capmark Investments, Morgan Stanley and UBS Securities. Autoimmune company Hansa...

...Epidiolex cannabidiol Seizures associated with tuberous sclerosis complex Phase III data; submit sNDA 1H19; 2H19 Hansa...

...she founded. Biophytis hired Samuel Agus to succeed her as CMO. He was VP of Hansa...

...effective April 2. He is VP of U.S. Immunology at AbbVie Inc. (NYSE:ABBV). Autoimmune company Hansa...

...donor-specific antibodies and safety. The product is a Streptococcus pyogenes enzyme that cleaves IgG antibodies. Hansa...
...donor-specific antibodies and safety Status: Interim Phase II data Milestone: Final Phase II data (3Q18) Chris Lieu IdeS Hansa...

...at Pfizer's R&D and Medical affairs division from 2002 to 2006. Autoimmune and transplant company Hansa...